Mobile Health Net Income Over Time
| MNDR Stock | 0.92 0.04 4.17% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mobile Health Performance and Mobile Health Correlation. Can Health Care Providers & Services industry sustain growth momentum? Does Mobile have expansion opportunities? Factors like these will boost the valuation of Mobile Health. Expected growth trajectory for Mobile significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Mobile Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (19.10) | Revenue Per Share | Quarterly Revenue Growth (0.54) | Return On Assets | Return On Equity |
Understanding Mobile health Network requires distinguishing between market price and book value, where the latter reflects Mobile's accounting equity. The concept of intrinsic value - what Mobile Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Mobile Health's price substantially above or below its fundamental value.
Understanding that Mobile Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mobile Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mobile Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Mobile health Network and related stocks such as Carisma Therapeutics, bioAffinity Technologies, and Artelo Biosciences Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CARM | (13 M) | (13 M) | (19.8 M) | (19.4 M) | (34.5 M) | (33.5 M) | 1.9 M | (29 M) | (33.7 M) | (107.5 M) | (28.3 M) | (336 K) | (61.2 M) | (86.9 M) | (60.5 M) | (54.4 M) | (57.2 M) |
| BIAF | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (7.3 M) | (6.3 M) | (8.2 M) | (7.9 M) | (9 M) | (8.1 M) | (8.5 M) |
| ARTL | (15.3 K) | (15.3 K) | (15.3 K) | (15.3 K) | (15.3 K) | (15.2 K) | (29.7 K) | (234.9 K) | (2.3 M) | (2.2 M) | (4.7 M) | (7.4 M) | (10.1 M) | (9.3 M) | (9.8 M) | (8.8 M) | (8.4 M) |
| REVB | 4.5 M | 4.5 M | 4.5 M | 4.5 M | 4.5 M | 6.2 M | 8.8 M | 16.3 M | 27.6 M | (3.6 K) | (136.4 K) | (12 M) | (10.8 M) | (120.3 K) | (15 M) | (13.5 M) | (12.9 M) |
| WOK | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 6 M | 865.2 K | 112 K | (3.5 M) | (1.1 M) | (965.4 K) | (917.1 K) |
| GTBP | 150 K | (3.7 M) | (5.2 M) | (501 K) | (23.5 M) | (21.5 M) | 9.8 M | (144.2 M) | (259.2 M) | (38.6 M) | (28.3 M) | (58 M) | (20.9 M) | (7.6 M) | (13.2 M) | (11.8 M) | (12.4 M) |
| PBM | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8.2 M | 8 M | (51.2 M) | 1 M | 910.6 K | 956.1 K |
| PTIX | (476 K) | (476 K) | (1 M) | (1.1 M) | (1.1 M) | (476 K) | (2.3 M) | (2.3 M) | (2.6 M) | (1.8 M) | (2.5 M) | (4.5 M) | (3.6 M) | (5 M) | (5.5 M) | (5 M) | (5.2 M) |
| AIMD | (300 K) | (1.3 M) | (650.8 K) | (622.6 K) | (622.6 K) | (521.9 K) | (670 K) | (617.4 K) | (1.3 M) | (1.6 M) | (1.5 M) | (3.9 M) | (14 M) | (13.8 M) | (14.9 M) | (13.4 M) | (12.7 M) |
| LIPO | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.8 K) | (61.7 K) | (1.9 M) | (2.6 M) | (4.6 M) | (5 M) | (4.5 M) | (4.3 M) |
Mobile health Network and related stocks such as Carisma Therapeutics, bioAffinity Technologies, and Artelo Biosciences Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Mobile health Network financial statement analysis. It represents the amount of money remaining after all of Mobile health Network Solutions operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Mobile health Network Solutions | MNDR |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | No 07-0607 Vision |
| Exchange | NASDAQ Exchange |
null 0.92
Additional Tools for Mobile Stock Analysis
When running Mobile Health's price analysis, check to measure Mobile Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mobile Health is operating at the current time. Most of Mobile Health's value examination focuses on studying past and present price action to predict the probability of Mobile Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mobile Health's price. Additionally, you may evaluate how the addition of Mobile Health to your portfolios can decrease your overall portfolio volatility.